Clinical study of continuous glucose monitoring system in patients with acute pancreatitis complicated with hyperglycemia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049998

Enrollment

Unknown

Registered

2021-08-15

Start date

2021-08-20

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

treatment group:Dynamic glucose monitoring and finger glucose monitoring

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old; 2. A clear diagnosis of AP; 3. Admission within 72 hours of onset; 4. Blood sugar>11.0mmol/L; 5. Patients gave informed consent, participated voluntarily and signed the informed consent form. The above five inclusion criteria must be met at the same time.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with any history of tumor diseases; 3. Patients with advanced or terminal stage of any disease.

Design outcomes

Primary

Measure	Time frame
Blood glucose fluctuation index;clinical scoring system;Posture Assessment Scale for Stroke PASS;Acute Physiology and Chronic Health Score;SOFA score for critically ill patients;Insulin dosage;	—

Countries

China

Contacts

Public ContactXia Qing

West China Hospital, Sichuan University

xiaqing@medmail.com.cn+86 18980601723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026